Sidus Space (Nasdaq: SIDU), a Space-as-a-Service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support, successfully completed critical command and data system testing required for mission success of its LizzieSat™ constellation. With this testing complete, LizzieSat is one step closer to its manifested 2023 launch from Cape Canaveral, Florida, on a SpaceX Falcon 9 rocket.

Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, announced the dosing of the first patient in the Phase 2 Harmonic™ clinical trial evaluating Lantern’s investigational new drug LP-300 in combination with chemotherapy for never smokers with advanced non-small cell lung cancer (NSCLC).

American Resources Corporation (Nasdaq: AREC), a next generation and socially responsible supplier of rare earth and critical elements, carbon and advanced carbon materials to the new infrastructure and electrification marketplace, reported revenues up 400% year-over-year in fiscal 2022.

Nutriband (Nasdaq: NTRB), entered into a three-year $2,000,000 Credit Line facility to provide financing through the FDA approval process into commercial scale manufacturing for the Company's patented lead product, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system.